Tin tức & Cập nhật

Treatment with nelonemdaz, a multitarget neuroprotectant that selectively blocks N-methyl-D-aspartate receptors and scavenges free radicals, does not appear to significantly improve stroke outcomes as compared with placebo, although nelonemdaz-treated patients show a greater tendency toward achieving modified Rankin Scale scores of 0–2 at 12 weeks, according to the results of a phase II study.

Individuals with nonaffective psychotic disorders appear to have a twofold higher risk of developing subsequent dementia compared with those who do not have such disorders, as reported in a recent study.

There appears to only be a very weak to no significant correlation between hypertension and cognitive function in late life, reports a recent study.